Mirion Technologies Business Summary

Mirion Technologies, Inc. (NYSE: MIR) is a global leader in radiation safety, science, and medicine, operating through two primary business segments: Nuclear & Safety and Medical. The company generates revenue through a high-margin mix of hardware sales (radiation detectors, spectroscopy systems, and monitoring equipment), recurring software-as-a-service (SaaS) platforms, and essential services such as occupational dosimetry and equipment calibration. As of early 2026, the Nuclear & Safety segment accounts for approximately 47% of total revenue, driven by the global expansion of small modular reactors (SMRs) and the recent acquisitions of Paragon Energy Solutions and Certrec. Mirion competes directly with Thermo Fisher Scientific, AMETEK (ORTEC), Fortive (Landauer), and Ludlum Measurements, maintaining a dominant market position by offering a comprehensive "cradle-to-grave" suite of solutions for the nuclear lifecycle and clinical oncology workflows. Founded in 2005 by Thomas D. Logan, the company was built as a consolidation platform for fragmented radiation detection assets. The current leadership team is led by Logan, who serves as Founder, CEO, and Chairman of the Board, bringing over 30 years of energy industry experience from roles at Global Dosimetry Solutions and Chevron. Key executives include Brian Schopfer (CFO and Medical Group President), James Cocks (Chief Technology Officer), and Shahmeer Mirza, who was appointed in late 2025 as the inaugural Chief Artificial Intelligence & Digital Officer to spearhead the firm's AI-driven digital transformation. Mirion is a publicly traded entity following a 2021 SPAC merger sponsored by Goldman Sachs, with a board of directors that includes notable industrial leaders such as Lawrence D. Kingsley (former CEO of IDEX) and Kenneth C. Bockhorst (CEO of Badger Meter).